Ashley Wagoner

Ashley Wagoner has extensive experience in clinical research and portfolio management. As Associate Director of Portfolio Management at Baxter International Inc. from February 2022 to June 2023, Ashley was responsible for the strategy and delivery of clinical trials for the Healthcare Systems & Technologies business segment. Previously, at BD, Ashley held various roles, including Senior Manager of Clinical Programs and Clinical Project Manager, contributing significantly to the INTREPID study. During tenure at IQVIA, Ashley managed multiple sites for a Phase IV Alzheimer's clinical trial. Earlier experience includes a graduate research project on dysautonomia at Wake Forest Baptist Health and a CRA training program. Ashley holds a PhD in Neuroscience from Wake Forest University and a BS in Neuroscience from Furman University.